Several nutritional pitfalls commonly occur when individuals begin GLP-1 therapy, potentially compromising health outcomes or treatment efficacy
Recurring Infections: Frequent sinus, urinary tract, and yeast infections
Under the law, outsourcing compounding pharmacies must comply with section 503B and current good manufacturing practice (CGMP) requirements
Common experiences during weeks 1-2 include mild nausea (reported by approximately 14% of participants at the 1 mg dose level), slight changes in appetite timing, increased awareness of fullness cues, and occasional fatigue as the body processes a new metabolic signal
Who GobyMeds Might Work Well For GobyMeds may work well for someone who wants a simple online process, wants to see plan pricing before the final step, and is mainly focused on getting access to GLP-1 support without bundling in a lot of extras
The long-acting GLP-1 agonists segment held the largest market share of 63% in 2025, driven by the offering of once-weekly dosing, which drastically enhances patient adherence over daily therapies